Decidr AI Industries Limited (ASX:DAI) has lodged an Initial Director's Interest Notice disclosing the appointment of David McCredie AM OBE as a director, effective 20 November 2026, with the filing confirming he holds no registered securities in the company at the time of appointment but has a contractual interest in a proposed issue of 1.5 million unlisted options.
Key Points
- David McCredie AM OBE appointed as director of Decidr AI Industries Limited, effective 20 November 2026
- Director holds nil securities in the company as registered holder at the date of the notice
- Letter of Appointment includes a proposed issue of 1.5 million unlisted options exercisable at $0.75
- The options expire three years from the date of issue and are subject to shareholder approval
Appointment of David McCredie AM OBE
Decidr AI Industries Limited, with ABN 28 614 347 269, filed an Initial Director's Interest Notice under ASX Listing Rule 3.19A.1 and section 205G of the Corporations Act in relation to the appointment of David McCredie AM OBE. According to the filing, McCredie's appointment as director took effect on 20 November 2026. The notice was submitted by the entity as agent for the director, in accordance with applicable regulatory requirements governing the disclosure of director interests in listed company securities.
Securities Holdings at Date of Notice
The filing discloses that David McCredie AM OBE holds nil securities in Decidr AI Industries Limited as a registered holder at the time of the notice. Part 2 of the Initial Director's Interest Notice, which covers securities of which the director is not the registered holder, is recorded as not applicable. Accordingly, the filing does not disclose any existing direct or indirect shareholding by the incoming director in the company at the date of his appointment.
Proposed Option Issue Under Letter of Appointment
Under Part 3 of the notice, the filing discloses that McCredie's Letter of Appointment provides for a proposed issue of 1.5 million unlisted options. The options are exercisable at $0.75 each and expire three years from the date of issue. The filing states that the issue of these options will be subject to shareholder approval. No registered holder is identified, as the securities have not yet been issued. The notice does not disclose further terms or conditions associated with the proposed option grant beyond those stated.




Please wait processing your request...